Tiedemann Advisors, LLC Cti Biopharma Corp Transaction History

Tiedemann Advisors, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 May 11, 2018	SELL	$2.7 - $4.06 $197,448 - $296,903	-73,129 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	73,129	73,129 $242,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Tiedemann Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Tiedemann Advisors, LLC with notifications on news.